+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5189611
  • Report
  • October 2020
  • Region: Global
  • 271 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aarhus University
  • Columbia University
  • Hycor Biomedical Inc
  • Metanomics Health GmbH
  • ProciseDx LLC
  • Svar Life Science AB
  • MORE
Summary

The publisher's Medical Devices sector report, “Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020“. Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aarhus University
  • Columbia University
  • Hycor Biomedical Inc
  • Metanomics Health GmbH
  • ProciseDx LLC
  • Svar Life Science AB
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Breast Cancer Overview

3 Products under Development
3.1 Breast Cancer - Pipeline Products by Stage of Development
3.2 Breast Cancer - Pipeline Products by Territory
3.3 Breast Cancer - Pipeline Products by Regulatory Path
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer - Ongoing Clinical Trials

4 Breast Cancer - Pipeline Products under Development by Companies
4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer - Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact

List of Tables
Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
Table 2: Auto-Immune Diseases - Pipeline Products by Territory
Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
Table 5: Auto-Immune Diseases - Ongoing Clinical Trials
Table 6: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
Table 7: Auto-Immune Diseases - Pipeline Products by Stage of Development
Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Biomarker Test - Autoimmune Diseases - Product Status
Table 10: Biomarker Test - Autoimmune Diseases - Product Description
Table 11: Biomarker Test - Multiple Sclerosis - Product Status
Table 12: Biomarker Test - Multiple Sclerosis - Product Description
Table 13: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Non-Invasive Diagnostic Test - Celiac Disease - Product Status
Table 15: Non-Invasive Diagnostic Test - Celiac Disease - Product Description
Table 16: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Biomarker Based Assay - Systemic Sclerosis - Product Status
Table 18: Biomarker Based Assay - Systemic Sclerosis - Product Description
Table 19: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status
Table 20: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description
Table 21: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: AIMS System - Cardiolipin IgG Test - Product Status
Table 23: AIMS System - Cardiolipin IgG Test - Product Description
Table 24: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status
Table 25: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description
Table 26: Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Diagnostic Assay - Neuromyelitis Optica - Product Status
Table 28: Diagnostic Assay - Neuromyelitis Optica - Product Description
Table 29: Diagnostic Assay - Paraneoplastic Disease - Product Status
Table 30: Diagnostic Assay - Paraneoplastic Disease - Product Description
Table 31: apDia nv Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Diagnostic Test - MS (Multiple Sclerosis) - Product Status
Table 33: Diagnostic Test - MS (Multiple Sclerosis) - Product Description
Table 34: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Anti-Squalene Antibody Assay - Product Status
Table 36: Anti-Squalene Antibody Assay - Product Description
Table 37: Autoimmune Disease Virus Assay - Graves' Disease - Product Status
Table 38: Autoimmune Disease Virus Assay - Graves' Disease - Product Description
Table 39: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status
Table 40: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description
Table 41: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status
Table 42: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description
Table 43: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status
Table 44: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description

List of Figures
Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
Figure 2: Auto-Immune Diseases - Pipeline Products by Territory
Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
Figure 5: Auto-Immune Diseases - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Aarhus University
  • Adaptive Biotechnologies Corp
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Amarantus Diagnostics Inc
  • apDia nv
  • Autoimmune Technologies LLC
  • Beckman Coulter Inc
  • Bellvitge Biomedical Research Institute
  • BG Medicine Inc
  • Biogen Inc
  • BIOHOPE Scientific SL
  • Biomedal SL
  • Bionure Farma SL
  • CDI Laboratories Inc
  • Celdara Medical LLC
  • Charite University Hospital of Berlin
  • Chronix Biomedical Inc
  • Cincinnati Children's Hospital Medical Center
  • Columbia University
  • Crescendo Bioscience Inc
  • Digna Biotech SL
  • DNAlytics SA
  • Enterome Bioscience SA
  • Exodus Biosciences LLC
  • Ezose Sciences Inc.
  • Flamentera AG
  • Genalyte Inc
  • GeNeuro SA
  • Grifols SA
  • Hannover Medical School
  • HealthTell Inc
  • Helmholtz Centre for Infection Research
  • HOB Biotech Group Suzhou Co Ltd
  • Hospital for Special Surgery
  • Hycor Biomedical Inc
  • Ignyta Inc
  • Immunarray Pvt Ltd
  • Immunodiagnostic Systems Holdings plc
  • Immunovia AB
  • ImmusanT Inc
  • Innobiochips
  • Inova Diagnostics Inc
  • IPDx Immunoprofiling Diagnostics GmbH
  • Iquity Labs Inc
  • Iron Horse Diagnostics, Inc.
  • Johns Hopkins University
  • Lankenau Institute for Medical Research
  • LineaGen Inc
  • Lophius Biosciences GmbH
  • Louisville Bioscience Inc (Inactive)
  • Max Delbruck Center for Molecular Medicine
  • Medica Corp
  • Medical & Biological Laboratories Co Ltd
  • Metabiomics Corporation
  • Metabolomic Technologies Inc
  • Metanomics Health GmbH
  • MSDx Inc
  • Myriad Genetics Inc
  • Nanosphere Inc
  • Neuro Vigor LLC
  • Northwestern University
  • NoToPharm srl
  • Numares AG
  • OmniBiome Therapeutics Inc
  • One Way Liver SL
  • OPKO Health Inc
  • Op-T-Mune Inc
  • Oxford Gene Technology Ltd
  • Oxford Immunotec Ltd
  • Pediatric Bioscience LLC
  • Penn State College of Medicine
  • ProciseDx LLC
  • Progentec Diagnostics Inc
  • Protagen AG
  • ProteinLogic Ltd
  • Quanterix Corp
  • Rambam Health Care Campus
  • Rappaport Family Institute for Research in the Medical Science
  • Regulus Therapeutics Inc
  • Roche Diagnostics International Ltd
  • Seattle Children's Hospital
  • Sengenics Corp Pte Ltd
  • Sequenom Inc
  • Shuwen Biotech Co Ltd
  • SomaLogic Inc
  • Southern Illinois University Carbondale
  • SQI Diagnostics Inc
  • Statens Serum Institut
  • Svar Life Science AB
  • TBG Diagnostics Ltd
  • The University of Manchester
  • The Walter and Eliza Hall Institute of Medical Research
  • Toscana Biomarkers Srl
  • University Health Network
  • University of Alberta
  • University of California San Francisco
  • University of Chicago
  • University of Colorado
  • University of Illinois at Chicago
  • University of Maryland Baltimore
  • University of Missouri
  • University of Oslo
  • University of Oxford
  • University of Pecs
  • University of Southern California
  • University Rovira i Virgili
  • US Biomarkers Inc
  • Washington University in St Louis
  • XEPTAGEN SpA
  • Yale University
Note: Product cover images may vary from those shown
Adroll
adroll